Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|December 19, 2006
Discovery and development of anticancer aptamersChristopher R Ireson, Lloyd R Kelland
Expert Opinion on Investigational Drugs|February 28, 2003
Farnesyl transferase inhibitors in the treatment of breast cancerLloyd R Kelland
Expert Opinion on Emerging Drugs|June 7, 2005
Emerging drugs for ovarian cancerLloyd R Kelland
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 24, 2002
An expeditious synthesis of cytotoxic pyrroloisoquinoline derivatives. Structure-activity comparative studies with isomeric pyrroloquinolinesMargarita Vlachou, Andrew Tsotinis, Lloyd R Kelland, et al.
Investigational New Drugs|January 5, 2007
Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Liangli Zhao, Elaine S Marshall, Lloyd R Kelland, et al.
Oncology Research|August 27, 2005
Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenolJillian Ferguson, Paul M Rogers, Lloyd R Kelland, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 2002
Synthesis and biological evaluation of an N10-Psec substituted pyrrolo[2,1-c][1,4]benzodiazepine prodrugJane M Berry, Philip W Howard, Lloyd R Kelland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Establishment and characterization of acquired resistance to the farnesyl protein transferase inhibitor R115777 in a human colon cancer cell lineVictoria Smith, Martin G Rowlands, Elaine Barrie, et al.
Pageof 4